Several authors have discussed whether or not the results given by the cumulative tech nique (8) and those given by the non-cumulative technique in the various preparations are identical, especially the shape, shift and maximum of dose-response curves to agonists obtain ed by both techniques(1-7). However, a study on potency comparisons of non-competitive antispasmodics with both techniques in the presence of excess external Ca2+ has not been reported. It is considered necessary to investigate the influence of excess external Ca 21, since the effects of the non-competitive antispasmodics such as papaverine are known to be antagonized by excess external Ca2+. In the experiments described in this paper, antioxy tocin activities of some non-competitive antispasmodics obtained by cumulative and non cumulative (single dose) techniques were compared in the isolated rat uterus when Ca2+ concentrations in the bathing medium were increased.
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Virgin female Wistar rats weighing 150 to 250 g were ovariectomized by the dorsal route, under ether anaesthesia, 24 hr after having been primed by a subcutaneous injection of estradiol benzoate (1.0 mg/kg). The rats were allowed to recover for more than a week before the experiment. The animal was stunned by a blow on the neck, the uterine horns were removed and placed in organ baths containing Locke-Ringer's solution, kept at 32'C and gassed continuously with air. The Locke-Ringer's solution used contained NaCl 154 mM, KCI 5.4 mM, CaCl2 2.2 mM, MgC12 2.1 mM, NaHCO3 5.9 mM and glucose 2.8 mM. Uterine contractions were isotonically recorded by means of a lever loaded with 0.5 g on a smoked drum. Non-competitive antispasmodics, papaverine, deoxycholate and Aspaminol (1,1-diphenyl-3-piperidinobutanol hydrochloride, Kowa Co. Ltd.), were allowed to act for 5 min and in their presence oxytocin was cumulatively or non-cumulatively added. When a high calcium concentration was required, CaC12 was added to the bathing medium and 1 min later the antispasmodics were applied. Antioxytocin activities of the antispasmodics were presented as pD2 ' values (3, 8) , pD2' being defined as the negative logarithm of the molar concentration of an antagonist necessary to inhibit the maximal contraction by 50%. In the cumulative technique, oxytocin was added in the absence and presence of the antispasmodic until a maximal response was reached. In the case of the single dose technique, a single supramaximal concentration of oxytocin (10-2 units/ml) was used to determine the maximal response and this concentration was applied several times to determine reproducibility of response. The 50 %-inhibition concentration was determined by application of the antispasmodic in two doses, one inhibited the oxytocin-induced maximal response by more than 50% and the other by less than 50%. The pD2' value was estimated from the 50%-inhibition concentration determined graphically from the inhibition percentages in two doses of the antispasmodic. These results suggest that the pD2' values obtained by using cumulative techniques and those by single dose ones in the isolated rat uterus may not be identical when higher Ca2+ con centrations in the bathing medium are used. Therefore, special consideration should be given to the effects of external Ca2+ concentrations when studies on the activities of non competitive antispasmodics are done using both techniques. In addition, our results support the data (9-11) that there are different mechanisms of action for these non-competitive antispasmodics. Ther. 143, 299-330 (1963) 9) TAKAGI, K., TAKAYANAGI, 1. AND FUJIE, K.: Chemicopharmacological studies on antispasmodic action. XV. Non-specific antispasmodic action on tracheal muscle. Chem. Pharm. Bull. 6, 716-720 (1958) 10) URUNO, T., TAKAYANAGI, I., TOKUNAGA, M., KUBOTA, K. AND TAKAGI, K.: Actions of papaverine, Aspaminol and bile salts and intracellular cyclic AMP level. Japan. J. Pharmacol. 24, 681-686 (1974) 11) URUNO, T., TAKAYANAGI, I., KUBOTA, K. AND TAKAGI, K.: Actions of bile salts and of papaverine and intracellular cyclic AMP in isolated rat uterus. Europ. J. Pharmacol. 32, 116-119 (1975) 
